Piper downgrades Zimmer to neutral, cites lack of catalysts (NYSE:ZBH)
2024-07-01
duoogle Piper Sandler has downgraded Zimmer Biomet (NYSE:ZBH) to neutral, citing a lack of near-term catalysts. The investment bank said it sees “limited” upside to large joint estimates for the second half of the year and 2025. It also noted the company is facing increased competition in the robotics marketContinue Reading